Yew Bio-Pharm Group Inc. (OTCMKTS:YEWB) posted its earnings results on Monday. The company reported $0.01 EPS for the quarter, Bloomberg Earnings reports. Yew Bio-Pharm Group had a return on equity of 23.77% and a net margin of 20.09%.
Shares of Yew Bio-Pharm Group (OTCMKTS:YEWB) opened at $0.22 on Tuesday. Yew Bio-Pharm Group has a 1-year low of $0.15 and a 1-year high of $0.47. The stock has a market capitalization of $11.41, a price-to-earnings ratio of 1.22 and a beta of -1.41.
About Yew Bio-Pharm Group
Yew Bio-Pharm Group, Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The Company operates through five segments: traditional Chinese medicine (TCM) raw materials, which is engaged in the production and sale of raw materials used for medicinal application in the pharmaceutical industry; yew trees, which is engaged in the cultivation and sale of yew seedlings, yew trees and potted yew trees; handicrafts, which is engaged in the manufacture and sale of furniture and handicrafts made of yew timber; wood ear mushroom, which includes the sale of wood ear mushroom, and others, which includes the sale of yew candles and pine needle extracts.
Receive News & Ratings for Yew Bio-Pharm Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yew Bio-Pharm Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.